biotech
Bio-AnalystSupplement research
person

Creatine

Selected research topic

Cognition

Findings differ across measurements or study conditions. The results below keep them separate.

Publications for this topic
6
Human comparison publications
2
Publications needing review
4

Findings in the studies

  • cognition

    • Results were mixed for this outcome.
      General population · Single ingredient · one-week periods
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: creatine exposure vs placebo sequence; detailed between-arm estimate not given
      Measurement time
      one-week periods
  • Working memory

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Single ingredient
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (1)
  • memory · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Partial research summary

Human studies reported mixed results for cognition.

These conditions come from related studies and may not describe a single paper.

Single-ingredient studies · Human studies · between-group comparison · comparator not confirmed

2 publications linked to this result (1 awaiting review included)

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 65.2 evidence score includes 9 independent human studies and 9 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 77

Papers linked to this topic 6 · distinct papers 6 · papers with a confirmed human comparison 2 · papers needing additional review 4

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • cognition: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 1
  • memory: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Working memory: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1

What the research found

cognition

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Working memory

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognition

The study needs further checking before its result can be interpreted.

Review · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

memory

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Review 3 combination findings and 0 findings that outperformed an ingredient alone.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

Gastrointestinal symptoms and muscle cramping1 papers
Creatine monohydrate was well tolerated but gastrointestinal symptoms and muscle cramping were reported as possibly related adverse events.Human studies · Randomized controlled trial

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

HMBCombined supplementation of HMB and Creatine monohydrate showed a synergistic effect on aerobic power at W8, W4, and WAT compared to the sum of effects from single supplements.
탄산수소나트륨Combined creatine and sodium bicarbonate supplementation significantly improved 30-m sprint and arrowhead agility performance in elite soccer players compared to placebo.
D-리보스A double-blind RCT in 53 patients with ischemic heart disease found that a combination supplement containing D-ribose, creatine, and vitamins improved cardiac double product and exercise tolerance compared to placebo, though the authors note the surrogate measure requires further validation.